207 related articles for article (PubMed ID: 38567911)
21. Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells.
De Luca T; Morré DM; Morré DJ
J Cell Biochem; 2010 Aug; 110(6):1504-11. PubMed ID: 20518072
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Sirtuin-1 hyperacetylates p53 and abrogates Sirtuin-1-p53 interaction in Cr(VI)-induced apoptosis in the ovary.
Sivakumar KK; Stanley JA; Behlen JC; Wuri L; Dutta S; Wu J; Arosh JA; Banu SK
Reprod Toxicol; 2022 Apr; 109():121-134. PubMed ID: 35307491
[TBL] [Abstract][Full Text] [Related]
23. A novel SIRT1 inhibitor, 4bb induces apoptosis in HCT116 human colon carcinoma cells partially by activating p53.
Ghosh A; Sengupta A; Seerapu GPK; Nakhi A; Shivaji Ramarao EVV; Bung N; Bulusu G; Pal M; Haldar D
Biochem Biophys Res Commun; 2017 Jul; 488(3):562-569. PubMed ID: 28526414
[TBL] [Abstract][Full Text] [Related]
24. Exogenous NAD(+) supplementation protects H9c2 cardiac myoblasts against hypoxia/reoxygenation injury via Sirt1-p53 pathway.
Liu L; Wang P; Liu X; He D; Liang C; Yu Y
Fundam Clin Pharmacol; 2014 Apr; 28(2):180-9. PubMed ID: 23384296
[TBL] [Abstract][Full Text] [Related]
25. Update on a tumor-associated NADH oxidase in gastric cancer cell growth.
Cheng HL; Lee YH; Yuan TM; Chen SW; Chueh PJ
World J Gastroenterol; 2016 Mar; 22(10):2900-5. PubMed ID: 26973386
[TBL] [Abstract][Full Text] [Related]
26. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.
Nihal M; Ahmad N; Wood GS
Cell Cycle; 2014; 13(4):632-40. PubMed ID: 24343700
[TBL] [Abstract][Full Text] [Related]
27. A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation.
De U; Son JY; Sachan R; Park YJ; Kang D; Yoon K; Lee BM; Kim IS; Moon HR; Kim HS
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30217020
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M
Gene; 2019 Aug; 711():143939. PubMed ID: 31220581
[TBL] [Abstract][Full Text] [Related]
29. TOPK inhibition accelerates oxidative stress‑induced granulosa cell apoptosis via the p53/SIRT1 axis.
Park JH; Park SA; Lee YJ; Joo NR; Shin J; Oh SM
Int J Mol Med; 2020 Nov; 46(5):1923-1937. PubMed ID: 32901866
[TBL] [Abstract][Full Text] [Related]
30. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
[TBL] [Abstract][Full Text] [Related]
31. Metformin induces microRNA-34a to downregulate the Sirt1/Pgc-1α/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents.
Do MT; Kim HG; Choi JH; Jeong HG
Free Radic Biol Med; 2014 Sep; 74():21-34. PubMed ID: 24970682
[TBL] [Abstract][Full Text] [Related]
32. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
33. Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress.
Hori YS; Kuno A; Hosoda R; Horio Y
PLoS One; 2013; 8(9):e73875. PubMed ID: 24040102
[TBL] [Abstract][Full Text] [Related]
34. Immune response evoked by tumor-associated NADH oxidase (tNOX) confers potential inhibitory effect on lung carcinoma in a mouse model.
Hsieh PF; Chueh PJ; Liu PF; Liao JW; Hsieh MK
Am J Cancer Res; 2019; 9(4):740-751. PubMed ID: 31106000
[TBL] [Abstract][Full Text] [Related]
35. Role of Sirtuin1-p53 regulatory axis in aging, cancer and cellular reprogramming.
Ong ALC; Ramasamy TS
Ageing Res Rev; 2018 May; 43():64-80. PubMed ID: 29476819
[TBL] [Abstract][Full Text] [Related]
36. SIRT1 and p53, effect on cancer, senescence and beyond.
Yi J; Luo J
Biochim Biophys Acta; 2010 Aug; 1804(8):1684-9. PubMed ID: 20471503
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in cellular model of Alzheimer's disease.
Kumar R; Nigam L; Singh AP; Singh K; Subbarao N; Dey S
Eur J Med Chem; 2017 Feb; 127():909-916. PubMed ID: 27836195
[TBL] [Abstract][Full Text] [Related]
38. Effect of polyclonal antisera to recombinant tNOX protein on the growth of transformed cells.
Chen CF; Huang S; Liu SC; Chueh PJ
Biofactors; 2006; 28(2):119-33. PubMed ID: 17379942
[TBL] [Abstract][Full Text] [Related]
39. Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives.
Bononi G; Citi V; Lapillo M; Martelli A; Poli G; Tuccinardi T; Granchi C; Testai L; Calderone V; Minutolo F
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235072
[TBL] [Abstract][Full Text] [Related]
40. Function of the SIRT1 protein deacetylase in cancer.
Stünkel W; Peh BK; Tan YC; Nayagam VM; Wang X; Salto-Tellez M; Ni B; Entzeroth M; Wood J
Biotechnol J; 2007 Nov; 2(11):1360-8. PubMed ID: 17806102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
